These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Structure-activity relationship of cystokinins: analogs exhibiting selective activity]. Martinez J; Rodriguez M; Lignon MF; Galas MC; Amblard M; Rolland M; Mendre C; Fulcrand P; Laur J; Bernad N J Pharm Belg; 1991; 46(1):9-16. PubMed ID: 2051303 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to the C-terminal tetrapeptide amide of gastrin. Assessment of antibody binding to cholecystokinin-pancreozymin. McGuigan JE Gastroenterology; 1968 Jun; 54(6):1012-7. PubMed ID: 5694819 [No Abstract] [Full Text] [Related]
4. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones. Stone SR; Giragossian C; Mierke DF; Jackson GE Peptides; 2007 Nov; 28(11):2211-22. PubMed ID: 17950490 [TBL] [Abstract][Full Text] [Related]
5. Metal ion binding affinities of gastrin and CCK in membrane mimetic environments. Lutz J; Weyher E; Moroder L J Pept Sci; 1995; 1(6):360-70. PubMed ID: 9223015 [TBL] [Abstract][Full Text] [Related]
6. Phylogeny of the cholecystokinin/gastrin family. Johnsen AH Front Neuroendocrinol; 1998 Apr; 19(2):73-99. PubMed ID: 9578981 [TBL] [Abstract][Full Text] [Related]
7. [Studies on the total synthesis of cholecystokinin-pancreozymin. Synthesis of the suitably protected fragment corresponding to the sequence 24--33 (author's transl)]. Wünsch E; Moroder L; Wilschowitz L; Göhring W; Scharf R; Gardner JD Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):143-52. PubMed ID: 7216168 [TBL] [Abstract][Full Text] [Related]
8. [Cholecystokinin-pancreozymin synthesis. Synthesis of [28-threonine,31-norleucine]- and [28-threonine,31-leucine]cholecystokinin-pancreozymin-(25-33)-nonapeptide]. Moroder L; Wilschowitz L; Gemeiner M; Göhring W; Knof S; Scharf R; Thamm P; Gardner JD; Solomon TE; Wünsch E Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):929-42. PubMed ID: 7275014 [TBL] [Abstract][Full Text] [Related]
9. Hepatic clearance of gastrin and cholecystokinin peptides. Doyle JW; Wolfe MM; McGuigan JE Gastroenterology; 1984 Jul; 87(1):60-8. PubMed ID: 6724275 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for myotropic activity of the gastrin/cholecystokinin-like insect sulfakinins. Nachman RJ; Holman GM; Haddon WF; Hayes TK Pept Res; 1989; 2(2):171-7. PubMed ID: 2520754 [TBL] [Abstract][Full Text] [Related]
11. Purification, amino acid sequence, synthesis, and receptor selectivity of alligator gastrin. Vigna SR; Elsey RM; Cheek AO; Faull KF; Reeve JR Gen Comp Endocrinol; 1997 Nov; 108(2):316-26. PubMed ID: 9356227 [TBL] [Abstract][Full Text] [Related]
12. Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling. Lutz J; Romano-Götsch R; Escrieut C; Fourmy D; Mathä B; Müller G; Kessler H; Moroder L Biopolymers; 1997 Jun; 41(7):799-817. PubMed ID: 9128441 [TBL] [Abstract][Full Text] [Related]
14. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685 [TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353 [TBL] [Abstract][Full Text] [Related]
16. Gastrin-the natural history of a peptide hormone. Gregory RA Harvey Lect; 1968-1969; 64():121-55. PubMed ID: 4926385 [No Abstract] [Full Text] [Related]
17. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor. Schmitz F; Pratt DS; Wu MJ; Kolakowski LF; Beinborn M; Kopin AS Mol Pharmacol; 1996 Aug; 50(2):436-41. PubMed ID: 8700154 [TBL] [Abstract][Full Text] [Related]
18. A peptide resembling COOH-terminal tetrapeptide amide of gastrin from a new gastrointestinal endocrine cell type. Larsson L; Rehfeld JF Nature; 1979 Feb; 277(5697):575-8. PubMed ID: 105297 [No Abstract] [Full Text] [Related]
19. [Pentapeptide derivatives of the C-terminal tetrapeptide of gastrin]. Portelli M; Renzi G Farmaco Sci; 1973; 28(4):316-22. PubMed ID: 4698887 [No Abstract] [Full Text] [Related]